Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
CurvaFix, Inc.
United States
- Bellevue, Washington
- 17/07/2023
- Series C
- $39,000,000
CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.
- Industry Medical Equipment Manufacturing
- Website https://curvafix.com/
- LinkedIn https://www.linkedin.com/company/curvafix-llc/
Related People
Steve DimmerFounder
United States -
Bellevue, Washington
30 years building medical technology companies. Deep experience leading development and commercialization of novel, disruptive health care solutions spanning diagnostic & therapeutic medical devices and drug delivery. Built world class teams in areas of orthopedics, pulmonology, oncology, diagnostics, and general surgery. Raised over $80 million from angels, VCs, family offices, and strategics. Inventor on over 100 U.S patents.
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)